University of Kentucky

UKnowledge
Toxicology and Cancer Biology Faculty
Publications

Toxicology and Cancer Biology

8-21-2015

The C-terminal Domain (CTD) of Human DNA GlycosylaseNEIL1 Is
Required for Forming BERosome Repair Complex with DNA
Replication Proteins at the Replicating Genome: DOMINANT
NEGATIVE FUNCTION OF THE CTD
Pavana M. Hegde
Houston Methodist Research Institute

Arijit Dutta
Houston Methodist Research Institute

Shiladitya Sengupta
Houston Methodist Research Institute

Joy Mitra
Houston Methodist Research Institute

Sanjay
Adhikari
Follow this
and additional works at: https://uknowledge.uky.edu/toxicology_facpub
Houston Methodist Research Institute
Part of the Medical Toxicology Commons
Right click to open a feedback form in a new tab to let us know how this document benefits you.
See next page for additional authors

Repository Citation
Hegde, Pavana M.; Dutta, Arijit; Sengupta, Shiladitya; Mitra, Joy; Adhikari, Sanjay; Tomkinson, Alan E.; Li,
Guo-Min; Boldogh, Istvan; Hazra, Tapas K.; Mitra, Sankar; and Hegde, Muralidhar L., "The C-terminal
Domain (CTD) of Human DNA GlycosylaseNEIL1 Is Required for Forming BERosome Repair Complex with
DNA Replication Proteins at the Replicating Genome: DOMINANT NEGATIVE FUNCTION OF THE CTD"
(2015). Toxicology and Cancer Biology Faculty Publications. 53.
https://uknowledge.uky.edu/toxicology_facpub/53

This Article is brought to you for free and open access by the Toxicology and Cancer Biology at UKnowledge. It has
been accepted for inclusion in Toxicology and Cancer Biology Faculty Publications by an authorized administrator
of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

The C-terminal Domain (CTD) of Human DNA GlycosylaseNEIL1 Is Required for
Forming BERosome Repair Complex with DNA Replication Proteins at the
Replicating Genome: DOMINANT NEGATIVE FUNCTION OF THE CTD
Digital Object Identifier (DOI)
https://doi.org/10.1074/jbc.M115.642918

Notes/Citation Information
Published in The Journal of Biological Chemistry, v. 290, no. 34, p. 20919-20933.
This research was originally published in The Journal of Biological Chemistry. Pavana M. Hegde, Arijit
Dutta, Shiladitya Sengupta, Joy Mitra, Sanjay Adhikari, Alan E. Tomkinson, Guo-Min Li, Istvan Boldogh,
Tapas K. Hazra, Sankar Mitra, and Muralidhar L. Hegde. The C-terminal Domain (CTD) of Human DNA
Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at
the Replicating Genome: DOMINANT NEGATIVE FUNCTION OF THE CTD. The Journal of Biological
Chemistry. 2015; 290:20919-20933. © the American Society for Biochemistry and Molecular Biology.
The copyright holder has granted the permission for posting the article here.

Authors
Pavana M. Hegde, Arijit Dutta, Shiladitya Sengupta, Joy Mitra, Sanjay Adhikari, Alan E. Tomkinson, GuoMin Li, Istvan Boldogh, Tapas K. Hazra, Sankar Mitra, and Muralidhar L. Hegde

This article is available at UKnowledge: https://uknowledge.uky.edu/toxicology_facpub/53

THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 34, pp. 20919 –20933, August 21, 2015
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.

The C-terminal Domain (CTD) of Human DNA Glycosylase
NEIL1 Is Required for Forming BERosome Repair Complex
with DNA Replication Proteins at the Replicating Genome
DOMINANT NEGATIVE FUNCTION OF THE CTD *
Received for publication, February 6, 2015, and in revised form, June 22, 2015 Published, JBC Papers in Press, July 1, 2015, DOI 10.1074/jbc.M115.642918

Pavana M. Hegde‡1, Arijit Dutta‡§1, Shiladitya Sengupta‡1, Joy Mitra‡, Sanjay Adhikari‡, Alan E. Tomkinson¶,
Guo-Min Li储, Istvan Boldogh**, Tapas K. Hazra‡‡, Sankar Mitra‡§ §§2, and Muralidhar L. Hegde‡§§¶¶3
From the ‡Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas 77030, the Departments of
§
Biochemistry and Molecular Biology, **Microbiology and Immunology, and ‡‡Internal Medicine, University of Texas Medical
Branch, Galveston, Texas 77555, the ¶Department of Internal Medicine and University of New Mexico Cancer Center, University of
New Mexico, Albuquerque, New Mexico 87131, the 储Department of Toxicology and Cancer Biology and Markey Cancer Center,
University of Kentucky College of Medicine, Lexington, Kentucky 40536, §§Weill Medical College of Cornell University, New York,
New York, and ¶¶Houston Methodist Neurological Institute, Houston, Texas 77030

The human DNA glycosylase NEIL1 was recently demonstrated to initiate prereplicative base excision repair (BER) of
oxidized bases in the replicating genome, thus preventing mutagenic replication. A significant fraction of NEIL1 in cells is present in large cellular complexes containing DNA replication and
other repair proteins, as shown by gel filtration. However, how
the interaction of NEIL1 affects its recruitment to the replication site for prereplicative repair was not investigated. Here, we
show that NEIL1 binarily interacts with the proliferating cell
nuclear antigen clamp loader replication factor C, DNA polymerase ␦, and DNA ligase I in the absence of DNA via its nonconserved C-terminal domain (CTD); replication factor C interaction results in ⬃8-fold stimulation of NEIL1 activity.
Disruption of NEIL1 interactions within the BERosome complex, as observed for a NEIL1 deletion mutant (N311) lacking
the CTD, not only inhibits complete BER in vitro but also prevents its chromatin association and reduced recruitment at replication foci in S phase cells. This suggests that the interaction of
NEIL1 with replication and other BER proteins is required for
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efficient repair of the replicating genome. Consistently, the
CTD polypeptide acts as a dominant negative inhibitor during
in vitro repair, and its ectopic expression sensitizes human cells
to reactive oxygen species. We conclude that multiple interactions among BER proteins lead to large complexes, which are
critical for efficient BER in mammalian cells, and the CTD interaction could be targeted for enhancing drug/radiation sensitivity of tumor cells.

A variety of oxidized base lesions in mammalian genomes,
induced by endogenous reactive oxygen species, both spontaneously generated during cellular metabolism and generated by
several genotoxic agents, including ionizing radiation, are
repaired via the base excision repair (BER)4 pathway (1). Many
among the mutagenic and cytotoxic oxidized bases contribute
to cellular sensitivity to ionizing radiation as well as radiomimetic and other drugs used in cancer therapy. Their repair,
which contributes to drug resistance, depends on BER competency of the cells. Thus, various strategies to target the BER
pathway are being explored for sensitizing cancer cells as an
adjuvant therapy modality with radiation or radiomimetic
drugs (2– 4).
We recently demonstrated that human DNA glycosylase
NEIL1 (Nei-like protein 1) plays a critical role in prereplicative
repair of oxidized lesions in S phase cells, a critical process for
preventing mutations in the replicating genome (5). NEIL1 is
4

The abbreviations used are: BER, base excision repair; Ab, antibody; FEN-1,
flap endonuclease 1; LigI, DNA ligase I; PNKP, polynucleotide kinase
3⬘-phosphatase; Pol␤, DNA polymerase ␤; Pol␦, DNA polymerase ␦; RFC,
replication factor C; CTD, C-terminal domain; sgRNA, single-guide RNA; IP,
immunoprecipitation; PLA, proximity ligation assay; aa, amino acid(s);
5-OHU, 5-hydroxyuracil; PCNA, proliferating cell nuclear antigen; LP-BER,
long patch BER; Ni-NTA, nickel-nitrilotriacetic acid.
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Background: DNA glycosylase NEIL1 initiates prereplicative repair of oxidized DNA.
Results: NEIL1 forms a multiprotein complex with DNA replication proteins via its C-terminal domain (CTD), allowing
recruitment at the replication fork. Isolated CTD inhibits this interaction and repair in vitro.
Conclusion: The interactions of NEIL1 are necessary for prereplicative repair.
Significance: The NEIL1 CTD could serve as a target for adjuvant cancer therapy.

Regulation Prereplicative Repair by NEIL1

Experimental Procedures
Cell Culture, Extract Preparation, and Cell Synchronization—The human embryonic kidney cell line HEK293 was
grown in DMEM-high glucose (Life Technologies, Inc.) containing 10% fetal bovine serum (FBS; Sigma), 100 units/ml
penicillin, and 100 g/ml streptomycin mixture (Life Technologies) at 37 °C with 5% CO2. HeLa S3 suspension culture
was grown in DMEM-high glucose with 10% FBS and
antibiotics.
Whole cell extracts were prepared by lysing the scrape-harvested adherent cells with a buffer containing 50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.1 mM EDTA, and
protease inhibitor mixture (Roche Applied Science). The
extracts were then treated with 500 units/ml each of DNase I
and RNase A (Ambion) or benzonase (Novagen) at 37 °C for 30
min and cleared by centrifugation for all experiments to remove
nucleic acids. Soluble nuclear and chromatin extracts were pre-
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pared using a protocol designed to minimize disruption of in
cellulo protein-protein interactions (high salt concentration
in the lysis buffers was avoided) as described previously (16). In
brief, cells were lysed first in cytoplasmic lysis buffer (10 mM
Tris-HCl, pH 8, 0.34 M sucrose, 3 mM CaCl2, 2 mM MgCl2, 0.1
mM EDTA, 1 mM DTT, 0.1% Nonidet P-40, and protease inhibitor), and nuclei were pelleted by centrifugation at 4,000 rpm
for 15 min at 4 °C. Nuclei were lysed with nuclear lysis buffer
(20 mM HEPES, pH 7.9, 3 mM EDTA, 10% glycerol, 150 mM
KOAc, 1.5 mM MgCl2, 0.5% Nonidet P-40, and protease inhibitor). The chromatin pellet was separated from the soluble
nuclear fraction by centrifugation at 14,000 rpm for 30 min at
4 °C. Chromatin was then extracted from the pellet by incubating with chromatin lysis buffer (150 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 150 mM KOAc, 10% glycerol, and protease inhibitor)
supplemented with 0.15 unit/l benzonase at 37 °C for 30 min
followed by centrifugation at 14,000 rpm for 30 min at 4 °C, and
the supernatant was collected (16). The extracts were stored at
⫺80 °C.
For synchronization, HEK293 cells were subjected to doublethymidine block as described previously (5, 17). Briefly, ⬃40%
confluent cells were treated with 10 mM thymidine for 18 h, and
then thymidine was removed for 4 h by washing with PBS
and adding fresh medium before adding thymidine (10 mM) and
incubating for 17 h. Cells were then stimulated to proliferate
with fresh media, harvested at various times, and processed for
cell cycle analysis as described elsewhere (5).
CRISPR-Cas-mediated Knockout (KO) of NEIL1 in HEK293
Line—The Tet-inducible CRISPR (iCRISPR) strategy was used
to knock out NEIL1 in HEK293 cells. Briefly, the single-guide
RNA (sgRNA) for the NEIL1 gene (AY257544.1) was designed
by screening target sequence with the sgRNA Designer on-line
tool (see the Broad Institute Web site). Two high activity
sgRNA target sequences were selected targeting exon-2
(sgRNA1, 5⬘-GTTTGTGAATGAGGCCTGCA-3⬘; sgRNA2,
5⬘-TGCAGGGCGCTGGTGTTCGG-3⬘) and were cloned into
lentiviral pLX-sgRNA plasmid (Addgene, catalog no. 50662) at
NheI/XhoI sites. HEK293 cells were co-transfected with
humanized Cas9 pCW-Cas9 plasmid (Addgene, catalog no.
50661) and customized pLX-sgRNA plasmids using Lipofectamine-2000. Cells stably expressing sgRNA and Cas9 were
double-selected with puromycin and blasticidin-S. Cas9
expression was induced by treating the cells to 0.5 g/ml doxycycline for 96 h. NEIL1 null clones were screened by
immunoblotting.
Size Exclusion Chromatography—Fractionation of nuclear
extract from HEK293 or HeLa cells was performed in a Sephacryl-300 high resolution gel filtration/size exclusion chromatography column (GE Healthcare, catalog no. S-300HR) using
ÄKTA pure (GE Healthcare) equipment. A column (16/60,
120-ml capacity) was optimized using standard molecular
weight marker mix (catalog no. MWGF1000-1KT) before
applying samples. 2 ml of nuclear extract was loaded for each
run in a buffer containing 1⫻ PBS, pH 7.4, at a 1.0-ml/min
(30-cm/h) flow rate. 2-ml fractions were collected. Column
equilibration and cleaning were performed per the manufacturer’s recommendations.
VOLUME 290 • NUMBER 34 • AUGUST 21, 2015
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unique among the five oxidized base-specific mammalian DNA
glycosylases in the Nth or Nei family for its S phase-specific
activation (1). NEIL1 and NEIL2 (in the Nei family, along with
the less characterized NEIL3 (6, 7)) are distinct from NTH1 and
OGG1 in the Nth family by their ability to act on lesions in
single-stranded DNA (ssDNA) substrates (8). NEIL1 functionally interacts with PCNA, FEN-1, and WRN (a RecQ helicase),
all of which are involved in DNA replication (10 –12). We have
previously shown that replication protein A, a mammalian
ssDNA-binding protein essential for DNA replication, inhibits
DNA glycosylase activity of NEIL1/NEIL2 in vitro with the replication fork-mimicking primer-template DNA substrate (13).
This inhibition should be essential in vivo for preventing double
strand break formation (5, 13). To further understand the function of NEIL1 in the replicating genome, we recently provided
direct experimental evidence for the “cow-catcher” role of
NEIL1 in prereplicative repair of oxidized DNA bases in the
template strand (5).
We observed that NEIL1 isolated from mammalian cells is
present in multiprotein “BERosome” complexes containing
DNA replication proteins, and this complex carried out proficient BER in vitro. Furthermore, NEIL1 physically interacted
with replication proteins, namely the PCNA clamp loader replication factor C (RFC), replicative DNA polymerase ␦ (Pol␦),
and DNA ligase I (LigI) via its disordered C-terminal domain
(CTD), which is also the critical region for its interaction with
other repair proteins (14, 15). Interestingly, RFC stimulated the
DNA glycosylase activity of NEIL1 and NEIL1-initiated complete repair, further supporting the involvement of NEIL1 in
replication-associated BER. The inability of a NEIL1 mutant
lacking the CTD to associate with chromatin raised the possibility that these replication proteins or some chromatin-associated proteins are essential for recruitment of NEIL1 to the
replicating genome. Moreover, isolated CTD significantly
inhibited NEIL1-initiated BER both in vitro and in cellulo in a
dominant negative manner. These data underscored a unique
feature of mammalian BER where repair is regulated via multiprotein interactions within the BERosome and also suggested
therapeutic potential of disrupting BERosome as a target to
enhance chemo/radiation sensitivity of cancer cells.

Regulation Prereplicative Repair by NEIL1
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was performed with anti-FLAG Ab (Sigma, catalog no. A8592)
and anti-BrdU (FITC BrdU flow kit, BD PharmingenTM, catalog
no. 559619).
Expression and Purification of Recombinant NEIL1 and DNA
Replication Proteins—Recombinant WT NEIL1, NEIL2, PNKP,
PCNA, Pol␦, RFC, LigI, and FEN-1 were purified as described
previously (9, 11, 12, 20 –23). The NEIL1-derived peptides
1–288, 1–311 (N311), 1–349, 289 –389, 289 –349, 312–389,
312–349, and 350 –389 were purified as described previously (5,
12, 14, 18), and their purity was confirmed by Coomassiestained SDS-PAGE.
Generation of TAT Fusion Peptide Expression Plasmids, Protein Purification, and Peptide Transduction in HEK293 Cells—
The protein transduction domain from HIV-TAT has been
widely utilized to deliver biologically active macromolecules
into a variety of cell types. TAT is an 11-aa (YGRKKRRQRRR),
Arg-rich peptide, which rapidly translocates into mammalian
cells (24 –26). We generated NEIL1 CTD (aa 289 –389 and aa
350 –389) bacterial expression clones in pMA1113 containing a
distal EGFP-HA tag-TAT-His10 tag. The pMA1113 backbone
plasmid was a generous gift from Susan Ledoux (25, 26).
Recombinant His/TAT fusion NEIL1 CTD peptides were
purified to homogeneity from Escherichia coli as described previously (5, 18, 27). Briefly, bacterial extracts containing Histagged peptides were separated by affinity chromatography on
an Ni2⫹ column, followed by chromatography on a HiTrap-SP
column (GE Healthcare).
In Vitro His and GST Affinity Pull-down Assay—His affinity
pull-down assays were carried out as described previously (11,
12). Briefly, WT NEIL1, its truncated mutant polypeptides, or
NEIL2 (20 pmol) were mixed with His-tagged Pol␦ or RFC (40
pmol), which was prebound to His-select magnetic nickel-nitrilotriacetic acid (Ni-NTA) beads (Qiagen) and incubated for
1 h at 4 °C with constant rotation in a buffer containing 1⫻ TBS,
5% BSA, and 10% glycerol. After washing the beads with TBS
containing 0.1% Triton X-100 and 400 mM NaCl, the bound
proteins were eluted with SDS sample dye and assessed for the
presence of NEIL1 and NEIL2 by immunoblotting. For affinity
pull-down assays using GST-tagged NEIL1 C-terminal peptides, glutathione-Sepharose beads (20 l) bound with GST
alone or GST-tagged NEIL1 C-terminal peptides (40 pmol)
were mixed with Pol␦, RFC, or LigI (20 pmol). After appropriate
washing, the SDS sample buffer-eluted proteins were probed
with antibodies for Pol␦, RFC, or LigI.
DNA Glycosylase Assay—Strand incision of oxidized basecontaining DNA by NEIL1 or NEIL2 was analyzed using 5⬘-32Plabeled 51-mer oligonucleotide containing 5-OHU at position
26 (12). The substrate (2 pmol) was incubated with NEIL1 (0.2
pmol) alone or in the presence of the indicated amounts of RFC
or FEN-1 at 37 °C for 15 min in a 10-l reaction mixture containing 40 mM HEPES, pH 7.5, 50 mM KCl, 100 g/ml BSA, and
5% glycerol. After stopping the reaction with formamide dye
(80% formamide, 20 mM NaOH, 20 mM EDTA, 0.05% bromphenol blue, and 0.05% xylene cyanol), the products were separated
by 20% polyacrylamide gel containing 8 M urea in 1⫻ Tris
borate-EDTA buffer, pH 8.4 (12, 21), and the radioactivity was
quantitated using a PhosphorImager (Amersham Biosciences)
and ImageQuant software.
JOURNAL OF BIOLOGICAL CHEMISTRY
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Co-immunoprecipitation (Co-IP) Analysis—HEK293 cells
were transfected with empty-FLAG vector-, NEIL1(WT)FLAG-, or NEIL1(N311)-FLAG-expressing plasmids. At 48 –56
h post-transfection, cells were harvested and lysed as described
(5, 14, 18). The benzonase-treated extracts were immunoprecipitated by rocking for 3 h at 4 °C with FLAG M2 antibody (Ab)
cross-linked to agarose beads (Sigma) (12, 13). The beads were
collected by centrifugation and washed three times with cold
Tris-buffered saline (TBS) containing 0.1% Triton X-100, and
NEIL1-FLAG protein was eluted from the beads. The eluted
immunocomplexes were separated on a 12% SDS-polyacrylamide gel and immunoblotted using Abs for Pol␦, RFC, LigI,
and other indicated Abs (Bethyl Laboratories), followed by
incubation with the corresponding HRP-conjugated secondary
antibodies (Sigma).
Chromatin Immunoprecipitation (ChIP)—ChIP analysis was
performed with exponentially growing cells and following the
procedure described previously (5, 19). Briefly, cells in 10-cm
plates were washed with PBS, cross-linked with 1% formaldehyde, lysed, and sonicated (XL-2000; QSonica LLC). IP was performed in the sonicated cleared lysate with 5 g of Abs or control IgG (Santa Cruz Biotechnology, Inc.) and Magna ChIP
Protein A magnetic beads (Millipore, catalog no. 16-661) overnight. Following IP, the beads were washed, protein-DNA complexes were eluted, and the cross-links were reversed. DNA was
purified using standard phenol/chloroform extraction and
finally dissolved in 10 mM Tris-HCl (pH 8). The ChIP and 1% of
the input DNA were subjected to SYBR Green-based real-time
PCR (7500 Real-Time PCR System; Applied Biosystems) with
appropriate primers (Table 1) and SYBR Premix Ex Taq
(TaKaRa). Data were calculated using the percent input
method (see the Life Technologies Web site).
Fluorescence Microscopy—HEK293 cells transiently expressing NEIL1(WT)-FLAG or NEIL1(N311)-FLAG were cultured
in 8-well chamber slides. To check nuclear localization of
ectopic NEIL1, the cells were fixed by incubating in 4% paraformaldehyde for 48 h, followed by permeabilization with 0.2%
Tween 20 solution in PBS, and then incubated with anti-FLAGFITC-conjugated Abs (Sigma). The nuclei were counterstained
with DAPI. Microscopy was performed on a Nikon Eclipse Ti
System at ⫻125 magnification. Co-localization was visualized
by superimposition of green and red images by using Nikon NIS
Elements version 3.5 (Nikon Instruments, Tokyo, Japan).
In Situ Proximity Ligation Assay (PLA)—HEK293 cells grown
overnight in 16-well chamber slides were fixed with 4% paraformaldehyde, permeabilized with 0.2% Tween 20, and incubated with a rabbit Ab for NEIL1 (9) and one of several DNA
replication proteins (mouse monoclonal; as indicated). The
PLA was performed using the Duolink PLA kit (OLink Bioscience, catalog no. LNK-92101-KI01) per the manufacturer’s
instructions. The nuclei were counterstained with DAPI, and
the PLA signals were visualized using a fluorescence microscope (Olympus) at ⫻200 magnification. For BrdU-NEIL1
PLA, HEK293 cells were grown in 60-mm plates and transfected with NEIL1(WT)-FLAG or NEIL1(N311)-FLAG plasmids. After 24 h, the transfected cells were plated in 8-well
chamber slides. The next day, log phase cells were pulse-labeled
with BrdU (10 M/10 min), as described previously (5), and PLA

Regulation Prereplicative Repair by NEIL1
TABLE 1
Primer oligonucleotide sequence used for quantitative real time PCR
amplification of ChIP porducts in Fig. 6C and for DNA damage analysis
in Fig. 9C
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The kinetic parameters were determined by incubating with
increasing amounts of unlabeled substrate (2.5–120 nM) added
to the reaction mixture containing 40 fmol of 5⬘-radiolabeled
substrate and 20 nM NEIL1 or NEIL1 plus 5 nM RFC for 4 min at
37 °C. Km, Vmax, and kcat were calculated from the linear range
of the reaction by regression analysis using Sigma plot software
(12, 14).
BER Assay—Complete BER was analyzed in a reconstituted
system containing recombinant proteins (PNKP, Pol␦, PCNA,
RFC, and LigI). The enzymes were incubated with 2 pmol of
damage-containing duplex oligonucleotide or 200 fmol of plasmid substrate (pUC19CPD) as described previously (5). Protein
concentrations were optimized for maximum product formation. A 20-l reaction mixture containing 1 mmol of ATP, 25
mol of unlabeled dNTPs, and 10 mol of [␣-32P]dNTPs (the
concentration of the corresponding cold dNTP was lowered to
5 M unless otherwise specified) in BER buffer (25 mM HEPESKOH, pH 7.9, 50 mM KCl, 2 mM MgCl2, 0.5 mM DTT) was
incubated for 30 min at 37 °C. Appropriate controls lacking
specific enzymes were included. After incubation for 30 min at
37 °C, the plasmid DNA was phenol/chloroform-extracted,
ethanol-precipitated, recovered, digested with N.BstNBI, and
resolved on a denaturing polyacrylamide gel and analyzed with
a PhosphorImager. The duplex oligonucleotide product of the
reaction was separated in situ in the denaturing gel.
Estimation of Oxidized Base/Single Strand Break Repair by
End Point PCR-based Quantitation—Nuclear genome-specific
semiquantitative PCR assays of long DNA fragments for measuring DNA damage were performed as described earlier (28,
29) using LongAmp TaqDNA polymerase (New England Biolabs) to amplify a 10-kb region of genomic DNA, using appropriate primer sequences (Table 1). Preliminary assays were carried out to ensure the linearity of PCR amplification with
respect to the number of cycles and DNA concentration. Unrepaired oxidized bases in DNA were measured by digestion with
Fpg/endonuclease III to generate strand breaks before PCR
analysis (29).
Clonogenic Cell Survival Assay—Log phase HEK293 cultures
were transfected with FLAG-NEIL1(289 –389) expression plasmid or the vector control. 24 h after transfection, cells were
trypsinized and transferred to 60-mm dishes (400 cells/dish).
24 h post-transfection, the cells were treated with glucose oxidase (0 –100 ng/ml) for 15 min. After allowing the cells to grow
in fresh medium for 10 days, the colonies were counted after
staining with crystal violet to calculate the surviving fraction
(14, 18).

Results
NEIL1 Forms BER-proficient Multiprotein Complexes with
DNA Replication Proteins in Human Cells—We have previously shown by co-IP analysis that NEIL1 associates with proteins involved in DNA replication machinery for prereplicative
repair of the template strand via long patch BER (LP-BER) (5).
To test whether NEIL1 associated with these replication proteins in a large repair-competent replication complex, we sizefractionated nuclear extracts (precleared with benzonase to
remove nucleic acids) from HEK293 cells in a Sephacryl 300 gel
filtration column. Immunoblotting of the eluates showed that
about one-third of NEIL1 was in a large megadalton fraction
(Fig. 1A), which also contained replication proteins PCNA,
RFC, Pol␦, LigI, FEN-1, and replication protein A. Another onethird of NEIL1, eluted in a ⬃400 –500-kDa fraction, mostly
contained single-nucleotide BER proteins (data not shown).
Nuclear extracts from HeLa S cells also showed a similar multiprotein complex containing NEIL1 (data not shown). Interestingly, NEIL1 in the large size fractions contained multiple
lower migrating bands, presumably representing post-translational modifications. Whereas NEIL1 is acetylated in the S
phase cells, a detailed account of these modifications will be the
topic of a future paper.5 Using a previously described BER assay
(5, 18), we show here that this complex fraction, containing
NEIL1 and replication proteins, was BER-proficient in vitro
(Fig. 1B). Furthermore, OGG1 eluted distinctly from NEIL1 in
gel filtration (Fig. 1A), which led us to test whether the complexes contained specific components required for downstream repair steps. For example, NEIL1 immunocomplex
contained PNKP but not APE1 (Fig. 1C), whereas OGG1 immunocomplex contained APE1 but not PNKP (Fig. 1D). PNKP is
required to remove the NEIL1 ␤␦-elimination product 3⬘P at
the strand break, and APE1 removes the OGG1 ␤-elimination
product 3⬘dRP or cleaves the AP site, mostly generated by
OGG1 due to its weak lyase activity (21, 30). The presence of
BER activity in the large complex supported our model in which
preformed repair complexes in mammalian cells are responsible for endogenous oxidized base repair, which led to the present study to characterize the NEIL1-containing prereplicative
repair complexes.
To test whether the loss of NEIL1 affects the formation of
replication complex in HEK 293 cells, we examined in cellulo
association of RFC with other replication proteins in CRISPR/
Cas-mediated NEIL1 null/KO HEK293 cells. A CRISPR/Cas9
NEIL1 KO HEK293 cell line (Fig. 1E) was generated as
described under “Experimental Procedures.” As we had
expected, based on nonessentiality of a DNA repair protein in
DNA replication, loss of NEIL1 did not significantly affect RFC
interaction with PCNA, FEN-1, Pol␦, or LigI, as analyzed by
RFC co-immunoprecipitation (Fig. 1F) and PLA (Fig. 1G).
These data suggest that whereas NEIL1 stably interacts with
replication proteins and is present in a replication protein
complex in human cells for prereplicative damage recognition and repair, it would not contribute significantly to the
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stability of the replication complex. It is more likely that
NEIL1, due to its affinity for most replication proteins, is
recruited to the preassembled replication complex. In any
event, although the spatial organization of these dynamic
complexes remains to be investigated, we asked whether
NEIL1 stably associates with individual DNA replication
proteins in a pairwise fashion.
NEIL1 Directly Interacts with Replication Proteins via Its
CTD—After establishing that NEIL1 associated with DNA replication proteins in human cells (5) and that these proteins
could be isolated as a NEIL1-containing multiprotein complex
(Fig. 1), we examined whether NEIL1 directly interacts with
DNA replication proteins RFC, Pol␦, and LigI in vitro. These
experiments were performed using His and GST fusion recomAUGUST 21, 2015 • VOLUME 290 • NUMBER 34

binant proteins via affinity pull-down assays. Immunoblotting
revealed that the His-RFC-bound Ni-NTA beads also contained both NEIL1 and NEIL2 (Fig. 2A (a)). We further mapped
the region of the NEIL1 CTD that interacted with RFC by a GST
pull-down assay using GST-tagged NEIL1 truncated polypeptides containing aa residues 312–389, 312–349, and 350 –389
(Fig. 2A (b)). Positive interactions were observed for residues
312–389 and 312–349 but not for the peptide corresponding to
residues 350 –389, indicating that the RFC binding interface is
localized within residues 312–349. Untagged GST served as the
control.
We next examined whether NEIL1 (or NEIL2) binarily interacted with Pol␦. Both NEIL1 and NEIL2 co-eluted with HisPol␦ bound to Ni-NTA-agarose beads, indicating a direct interJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 1. NEIL1 forms a specific BER-proficient multiprotein complex with DNA replication proteins in human cells that contains PNKP but not APE1.
A, HEK293 cell nuclear extracts were precleared with benzonase and fractionated on a Sephacryl 300 gel filtration column. A significant fraction of NEIL1 elutes
as megadalton-size complex (⬎2000 kDa), which contains DNA replication proteins. B, complete LP-BER assay was performed with 5⬘-biotinylated duplex
oligonucleotide substrate (51 nucleotides long) with 5-OHU at position 26. Sephacryl fractions 44 and 45, containing NEIL1 and replication proteins, showed
repair activity. In contrast, fraction 80, mostly containing uncomplexed NEIL1 and a small amount of PNKP and Pol␤, generated unligated repair products.
Complete BER was achieved with fraction 62 when supplemented with recombinant PNKP, Pol␤, and DNA ligase III␣ (LigIII␣). C and D, co-IP of FLAG-NEIL1 from
HEK293 cells contained PNKP but not APE1; conversely, co-IP of FLAG-OGG1 contained APE1 but not PNKP, suggesting that NEIL1 and OGG1 form unique BER
complexes containing essential downstream repair proteins. E–G, CRISPR/Cas-mediated NEIL1 KO in HEK293 cells (E) does not affect RFC in cellulo association
with PCNA, Pol␦, or LigI, as analyzed by RFC co-IP (F) and PLA (G).
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action between these proteins (Fig. 2B). Interaction mapping
analysis by His or GST pull-down assays showed that NEIL1
fragments of aa 289 –389, 312–389, and 312–349 bound to
Pol␦, but aa 1–288 and 350 –389 fragments did not (Fig. 2B, a
and b). Together, these data suggested that aa 312–349 in the
NEIL1 CTD served as the minimal peptide for interaction with
Pol␦. This was also confirmed by a Far-Western analysis
showing a positive interaction with both NEIL1(WT) and
NEIL1(N349) but not with NEIL1(N311) peptides (Fig. 2B (c)).
A reverse Far-Western analysis with Pol␦ subunits separated in
SDS-PAGE revealed interaction of NEIL1 with both the p66
and p50 subunits (Fig. 2B (d)).
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Similarly, we confirmed in vitro binding of NEIL1 with LigI
and mapped the interacting peptide to residues 289 –349 in
NEIL1 by Far-Western (Fig. 2C (a)) and GST co-elution analysis (Fig. 2C (b)). In addition, we have previously shown pairwise
interaction of NEIL1 with PCNA, FEN-1, and replication protein A (11–13). Together, these data show that NEIL1 directly
interacts with most DNA replication proteins to form a large
multiprotein prereplicative repair complex, which was stabilized by pairwise interactions with individual replication proteins via the NEIL1 CTD. Although it is intriguing that a BERinitiating enzyme like NEIL1 or NEIL2 interacted with most
replication/downstream repair proteins, including RFC and
VOLUME 290 • NUMBER 34 • AUGUST 21, 2015
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FIGURE 2. Pairwise interaction of NEIL1 with DNA replication proteins in vitro via CTD. A, interaction with RFC. a, in vitro His tag affinity analysis with
recombinant proteins shows that both NEIL1 and NEIL2 directly interact with His-RFC. b, GST-NEIL1 CTD fragments with aa 312–389 and 312–349 but not
aa 350 –389 co-elute with RFC. GST alone was used as the control. B, interaction with Pol␦. a, full-length NEIL1 and its CTD peptide aa 289 –389 but not
aa 1–288 polypeptide were co-eluted with His-Pol␦. WT NEIL2 also co-eluted with His-Pol␦. b, as with RFC, Pol␦ was co-eluted with GST-NEIL1 CTD
peptides aa 312–389 and 312–349 but not with aa 350 –389. c, Far-Western analysis of Pol␦ shows its interaction with NEIL1(WT) and the polypeptide aa
1–349 but not the aa 1–311 peptide. FEN1 served as a positive control. d, reverse Far-Western analysis (Pol␦ on the membrane with four subunits) shows
interaction of NEIL1 with p66 and p50 subunits. Pol␤ served as the positive control. C, interaction with LigI. a, Far-Western analysis of NEIL1 CTD peptides
indicates that LigI binding requires aa 289 –349 in the NEIL1 CTD. b, co-elution of LigI with GST-NEIL1 fragments aa 289 –389 and 289 –349 but not aa
312–389 or 312–349. D, the interaction mapping of NEIL1 domains with RFC, Pol␦, and LigI shows distinct but overlapping binding residues within the
CTD.
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FIGURE 3. Loss of CTD abrogates in cellulo association of NEIL1 with DNA replication proteins. A, FLAG-IP from FLAG-NEIL1(N311)-expressing HEK293 cells
shows a significantly reduced level of LigI, RFC, and Pol␦, but not PCNA, compared with that from FLAG-NEIL1(WT)-expressing cells. PCNA binding requires
residues 289 –312, as shown previously (11). B, PLA of WT versus N311 mutant NEIL1-FLAG with replication proteins confirms that CTD is required for binding.
C, quantitation of PLA foci from 25 or more cells. Error bars, S.E.
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mid (Fig. 4D). As expected, the presence of all LP-BER factors,
including NEIL1, generated completely repaired product (Fig.
4E, lane 4). Because RFC stimulated NEIL1 glycosylase activity
via direct interaction, we examined whether RFC stimulated
complete repair. A dose-dependent enhancement of LP-BER
was observed with increasing RFC amount (Fig. 4E, lanes 5 and
6). As expected, NEIL1 was rate-limiting (Fig. 4E, lanes 1, 7,
and 8).
Functional stimulation of NEIL1, but not NEIL2, by RFC was
intriguing, because both NEIL1 and NEIL2 physically interact
with RFC. We previously made a similar observation with
PCNA (11). To test whether this was a common feature of the
interaction of NEILs with replication proteins, we then analyzed the impact of FEN-1 binding on NEIL2 activity. FEN-1,
which activated NEIL1 in vitro (12) (Fig. 5B, lane 6) did not
affect NEIL2 (Fig. 5B, lanes 2–5), although direct physical interaction was observed with both NEIL1 and NEIL2 (Fig. 5A).
Interestingly, the binding affinity, measured by the dissociation
constant (Kd) of FEN-1 for NEIL1, was 3-fold higher than that
for NEIL2 (Fig. 5, C and D). This differential affinity may
explain the differential functional association of replication
proteins with the two NEIL glycosylases, which was consistent
with our model of the back-up role for NEIL2 in BER during
replication (5). Furthermore, unlike RFC, Pol␦ and LigI did not
affect NEIL1 activity in vitro (data not shown).
Deletion of CTD Impairs NEIL1 Recruitment at Replication
Foci—We have previously shown the cell cycle phase-specific
recruitment of NEIL1 to chromatin along with DNA replication proteins (5). To test the role of the CTD in NEIL1 chromatin recruitment, we first confirmed comparable expression of
ectopic NEIL1(WT) versus NEIL1(N311) in HEK293 cells (Fig.
6A). Although the N311 mutant and WT NEIL1 showed comparable nuclear localization, as indicated by immunofluorescence microscopy (Fig. 6B) and immunoblotting of the nuclear
fraction (Fig. 6A), the N311 mutant was absent in the chromatin
fraction, unlike WT NEIL1 (Fig. 6A). This suggested that the
CTD is required for NEIL1 to associate with chromatin. To
test this quantitatively in S phase cells, we performed ChIP
analysis on FLAG-tagged NEIL1(WT)- versus NEIL1(N311)expressing cells with a FLAG antibody. Quantitative ChIP
analysis showed significantly higher binding of NEIL1(WT)
JOURNAL OF BIOLOGICAL CHEMISTRY
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LigI, the biological role of such large complexes where the components directly interact with each other warrants further
investigation.
NEIL1 CTD Is Required for Its Complex Formation with DNA
Replication Proteins in Cells—Extending our in vitro interaction mapping studies, we used co-IP to demonstrate that
FLAG-NEIL1(WT) but not the FLAG-NEIL1(N311) mutant,
which lacked the CTD, interacted with RFC, Pol␦, LigI, and
FEN-1 (Fig. 3A). PCNA binding was comparable with WT and
N311 NEIL1, as reported previously (11), because PCNA binding requires residues 289 –311. Involvement of the NEIL1 CTD
in the in cellulo association of NEIL1 with DNA replication
proteins was further confirmed in situ by PLA (Fig. 3B). Strong
interaction was observed between NEIL1(WT) and Pol␦, RFC,
PCNA, FEN1, and LigI, indicated by a significant number (⬎10/
nuclei) of PLA foci in the nucleus. The number of foci were
significantly reduced for the N311 mutant, nearly 3-fold less
than with WT NEIL1 (Fig. 3, B and C). Taken together, these
data indicate that NEIL1 exists in complexes with the replication proteins in vivo using a minimal peptide in its CTD. We
previously observed that NEIL2 interacted with replication
proteins at a weaker level than NEIL1 in human cells (5).
RFC Enhances NEIL1 DNA Glycosylase Activity and NEIL1initiated BER in Vitro—We tested whether the base excision/
strand incision activity of NEIL is affected by RFC. In vitro
activity assays were performed as described using purified
NEIL1(WT), NEIL1(N311), and NEIL2. RFC significantly stimulated (⬃8-fold) NEIL1 to incise the primer-template substrate
at the damaged base site in a concentration-dependent manner
(Fig. 4A). Activity of neither NEIL2 nor NEIL1(N311) (which
lacked the RFC binding domain) was affected. Furthermore,
stimulation of NEIL1 activity by RFC was 2-fold higher with the
primer-template substrate than with the duplex substrate
(Fig. 4B).
Analysis of the kinetic parameters (Fig. 4C) of NEIL1 activity
indicated that RFC increased both the substrate affinity (2–3fold reduction in Km) and product release (⬃4-fold increase in
kcat) of NEIL.
We reconstituted NEIL1-initiated LP-BER in vitro (characterized by incorporation of [32P]dGMP at the second nucleotide position from the lesion) using purified Pol␦, PCNA, RFC,
FEN-1, LigI, and PNKP with a 5-OHU lesion-containing plas-
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relative to the N311 mutant at the same representative
sequences in S phase cells, but not in the G1/S boundary cells
(Fig. 6C).
Next, we utilized PLA to examine the role of the CTD in
NEIL1 recruitment at the replication fork after pulse-labeling
the HEK293 cells with BrdU. BrdU after pulse-labeling for a
short time (⬎10 min) is observed in discrete foci and was used
to identify replication forks (5, 31, 32). Here, we developed a
novel approach using PLA with BrdU to confirm localization of
NEIL1 at the replication forks. A significant number of PLA foci
were observed for FLAG/BrdU in FLAG-NEIL1(WT)-expressing cells, but no PLA foci were observed in cells expressing
FLAG-NEIL1(N311) (Fig. 6D). Taken together, these results
confirm that the CTD is essential for the recruitment of NEIL1
to replication forks.
The NEIL1 CTD Is Required for Efficient BER with Replication Proteins—We previously showed that the CTD, although
dispensable for NEIL1 excision activity, contributed cellular
resistance to oxidative stress via its interactions with single-
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nucleotide BER proteins (18). To determine the impact of the
CTD on the prereplicative repair function of NEIL1, we examined the effect of CTD deletion on LP-BER involving DNA replication proteins. The repair reaction was reconstituted with a
5-OHU-containing plasmid substrate. LP-BER, represented by
labeled, second nucleotide incorporation from the lesion site in
a plasmid substrate (Fig. 4D), showed that repair initiated by
NEIL1(N311) was significantly less efficient relative to
NEIL1(WT) or NEIL1(1–349), which contained the interaction domain (Fig. 7A). No repair was observed with
NEIL1(1–288), which is known to be inactive (18, 30). Similar observations were made using a linear duplex substrate
(Fig. 7B). As shown previously (18), the DNA glycosylase
activity of NEIL1(WT), NEIL1(1–311), and NEIL1(1–349)
were comparable, whereas NEIL1(1–288) was inactive (Fig.
7C). Together, these results showed that the NEIL1 CTD,
which is dispensable for its glycosylase activity, is crucial for
its interactions with replication proteins, resulting in efficient repair of oxidized bases.
VOLUME 290 • NUMBER 34 • AUGUST 21, 2015
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FIGURE 4. Activation of NEIL1 but not NEIL2 by RFC via pairwise interaction. A, 5-OHU lesion excision/lyase activity of NEILs with 5⬘-32P-labeled primertemplate oligonucleotide substrate shows that RFC stimulates WT NEIL1 by ⬃8-fold but does not affect N311 mutant lacking the CTD. NEIL2 activity was also
not affected. B, RFC stimulated NEIL1 activity with duplex oligonucleotide substrate, albeit to a lesser extent compared with the primer-template substrate. C,
kinetic parameters reveal RFC stimulation of NEIL1 activity primarily by increasing its turnover (⬃5-fold increase in Kcat), although a ⬃2.5-fold decrease in Km
suggested an increase in substrate affinity as well. D–E, RFC activates NEIL1-initiated LP-BER (lanes 5 and 6) with DNA replication proteins. Repair was carried out
with pUC19CPD plasmid substrate containing a single 5-OHU lesion (D) (5, 14). The LP-BER reaction was optimized for linear dose dependence for the NEIL1
level (lanes 7 and 8). Error bars, S.E.
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FIGURE 5. Pairwise interaction and differential stimulation of NEILs with FEN-1. A, Far-Western analysis and His tag co-elution of NEIL1 and
NEIL2 with WT FEN1 and its C-terminal domain (aa 328 –380). B, BER activity with 5-OHU-containing bubble oligonucleotide (33) shows that FEN-1
stimulates NEIL1 but not NEIL2. C and D, binding (Kd) measurement using fluorescence spectroscopy (12, 14) showed 3-fold reduced affinity of the FEN-1
CTD (aa 328 –380) for NEIL2 relative to NEIL1. The FEN-1 CTD lacking Trp or Tyr residues has a negligible contribution to the fluorescence. Error bars, S.E.

Ectopic CTD Peptide Acts as a Dominant Negative Inhibitor
of BER—The present study and our previous observations
cumulatively demonstrated that mammalian BER is carried out
by repair complexes guided by repair-initiating glycosylases,
including NEIL1. NEIL1 utilizes its disordered CTD for most of
its interactions. Hence, we tested whether ectopic CTD could
inhibit BER by inhibiting NEIL1-BERosome formation. When a
recombinant CTD peptide was added in vitro, in a LP-BER
reaction initiated by NEIL1 and replication proteins using a
5-OHU-containing duplex substrate (Fig. 8A), a dose-dependent inhibition of repair was observed (Fig. 8B, lanes 2–5). The
non-interacting peptide, aa 350 –389, did not inhibit NEIL1AUGUST 21, 2015 • VOLUME 290 • NUMBER 34

initiated BER (Fig. 8B, lanes 7 and 8). Complete BER initiated
with FLAG-NEIL1 immunocomplex from HEK293 cells was
similarly reduced in the presence of the purified CTD peptide
(Fig. 8B, lanes 9 and 10).
The CTD Peptide Sensitizes HEK293 Cells to Reactive Oxygen
Species by Impairing BER—We then examined the effect of
ectopic CTD at the cellular level. We generated TAT fusion
NEIL1 CTD peptides, aa 289 –389 and aa 350 –389, also with a
GFP tag. NEIL1 aa 289 –389 contained the common interaction
domain, whereas aa 350 –389 was outside of the interaction
region and served as a control. Transduction of TAT fusion
peptides in HEK293 cells was confirmed by green fluorescence
JOURNAL OF BIOLOGICAL CHEMISTRY
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(Fig. 9B). The cells were then exposed to 75 ng/ml glucose oxidase (reactive oxygen species source), grown for 4 –5 h to
allow time for repair, and then harvested to isolate the
genomic DNA. Quantitative PCR analysis of genomic DNA
following Fpg and EndoIII treatment (to excise unrepaired
oxidized base lesions) showed that unrepaired oxidized base
damage was significantly higher in cells transduced with
TAT-NEIL1 aa 289 –389 (Fig. 9C). Similar results were
observed in cells expressing FLAG-NEIL1 aa 289 –389 compared with those expressing empty vector or non-interacting
peptide (aa 350 –389) (Fig. 9C).
Finally, we tested whether ectopic CTD affects NEIL1 in cellulo association with replication proteins. Fig. 9D shows significant (⬎5-fold) reduction in the number of PLA foci for
NEIL1 pair with RFC, Pol␦, or LigI. Moreover, the TAT-
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NEIL1 aa 289 –389 peptide strongly inhibited cell survival
after glucose oxidase treatment, as measured by a clonogenic
assay (Fig. 9E). Together, these studies confirmed that the
NEIL1 CTD peptide could inhibit in cellulo BER in a dominant negative manner by inhibiting NEIL1-BERosome formation and sensitizes cells via accumulation of unrepaired
oxidized DNA bases.

Discussion
The minimal BER reaction in vitro using naked DNA substrate was previously shown to require only four enzymes,
including the repair-initiating DNA glycosylase (1). However,
subsequent studies indicated the involvement of more than 20
additional polypeptides in mammalian BER comprising several
subpathways. These proteins include scaffolds, damage senVOLUME 290 • NUMBER 34 • AUGUST 21, 2015
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FIGURE 6. Loss of CTD abolishes recruitment of NEIL1 to chromatin and replication fork. A, immunoblotting of whole cell extracts, soluble nuclear fraction,
and chromatin fraction from HEK293 cells transiently expressing FLAG-NEIL1(WT) or FLAG-N311 shows an absence of the latter in chromatin. B, immunofluorescence staining with FITC-conjugated anti-FLAG antibody shows comparable nuclear localization of N311 and WT NEIL1. C, real-time ChIP-PCR analysis at
arbitrary genome sequences (RAR␤2 or CDKN1A promoter regions) in double-thymidine block-synchronized HEK293 cells at the G1/S boundary versus S phase
shows a requirement of CTD for S phase-specific recruitment of NEIL1 to chromatin. D, log phase HEK293 cells ectopically expressing WT NEIL1-FLAG or
N311-FLAG were pulse-labeled with BrdU. PLA was performed with anti-FLAG and anti-BrdU Ab. A significant number of PLA foci in WT NEIL1-expressing cells
indicates its recruitment at the replication fork/foci. An absence of PLA foci in N311-expressing cells confirms the requirement of the CTD. 25 cells were
analyzed for quantitation. Error bars, S.E.
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sors, RNA/DNA binding proteins, and proteins involved in
DNA transcription and replication (5, 12, 14, 33, 34). We
recently demonstrated that cross-talk of BER proteins in the
NEIL-initiated subpathway and DNA replication machinery
ensures repair of mutagenic oxidized lesions prior to DNA replication in S phase cells (5).
Excision repair pathways, including BER and nucleotide
excision repair, are commonly believed to comprise multistep,
sequential hand-off reactions (35, 36). BER steps include damaged base recognition, its excision and strand scission at the
damage site, end-trimming at DNA breaks, and finally repair
synthesis followed by nick ligation (1). During hand-off repair,
individual steps would require sequential recruitment of specific components.
Whereas the minimal pathway for BER may be operative in
prokaryotes (and possibly other primitive organisms), recent
observations by us and others suggest that mammalian BER is
far more complex and more highly regulated, which is supported by the following observations. (a) Several accessary and
AUGUST 21, 2015 • VOLUME 290 • NUMBER 34
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FIGURE 7. The CTD is dispensable for NEIL1 base excision/AP lyase
activity but is required for optimum repair activity involving replication proteins. A, complete LP-BER assay with pUC19CPD as in Fig. 4D,
using recombinant proteins, shows proficient repair with WT NEIL1 but
not with the nested CTD deletion polypeptides aa 1–349 and 1–311. The
1–288 mutant was inactive, as shown previously (30). B, similar results
were obtained with linear duplex oligonucleotide substrate for WT NEIL1
and N311 mutant. C, base excision/AP lyase activity was comparable for
WT NEIL1, 1–349, and 1–311. The 1–288 polypeptide was inactive. Error
bars, S.E.

scaffold proteins are involved in BER, many of which stably
interact with most essential BER proteins (34). (b) BER co-opts
proteins involved in DNA replication, transcription, and stress
response, presumably to select specific repair subpathways (5,
33, 34). (c) Multiple pairwise interactions are common among
the BER components, often involving BER-initiating DNA glycosylases, which even interact with DNA ligase, the last enzyme
in the repair pathway (18, 30). (d) Finally, these interactions
may involve common interaction interfaces of the repair-initiating enzyme, namely DNA glycosylase or APE1, most of which
contain a disordered, non-conserved terminal peptide segment, absent in the E. coli ortholog (1, 15, 34, 37). These studies
raise the issue of the intracellular state of mammalian BER components. Specifically, are they present as individual entities or
in preformed complexes? In the latter scenario, such complexes
would remain bound to the DNA segment containing a substrate lesion until completion of repair. Alternatively, they
could be recruited and handed off sequentially as individual
repair proteins.
Thus far, our studies have provided support for the presence
of preformed BER complexes that carry out sequential reaction
steps. We observed that nearly half of NEIL1 in the nuclear
extracts from HeLa and HEK293 cells existed in multiprotein
complexes, which also contained significant levels of DNA replication proteins. These complexes, separated by size fractionation after removal of DNA, were proficient in carrying out
complete BER in vitro. Although multiprotein complexes for
DNA repair were characterized previously, particularly for
nucleotide excision repair (35, 36, 38), our studies for the first
time demonstrated the existence of a BERosome in human
cells, which included replication proteins needed for the replication-associated repair subpathway. Surprisingly, NEIL1
interacted directly with most of the proteins present in the
complex in a DNA-independent manner, often resulting in its
activity enhancement (12, 14). In this report, we have shown
marked stimulation of NEIL1 by RFC, an unexpected observation considering that the role of RFC was postulated to be as the
PCNA clamp loader. However, contrary to this previous notion,
recent studies have indicated the key role of RFC in coordinating LP-BER, especially in regulating FEN-1 and LigI functions
(39). RFC is also required for unloading of PCNA after completion of repair, necessitating its presence in the BER complex throughout the repair process (40, 41). Furthermore,
PCNA and FEN-1 also activate NEIL1, whereas replication
protein A inhibits NEIL1 activity, all of which require direct
protein-protein interaction (5, 13). As mentioned previously, the NEIL1-BERosome complex exists in the absence of
DNA, suggesting that the entire preformed complex is
recruited to or formed on the chromatin to ensure complete
BER at the damaged sites.
As observed earlier for single-nucleotide BER, the disordered
CTD (aa 289 –349) of NEIL1 also interacted with replication
proteins. Involvement of a relatively short peptide domain in
NEIL1 in its interactions with as many as 20 partner proteins
suggests the formation of dynamic complexes where NEIL1
appears to act as a “hub protein” (37). This is consistent with
our cow-catcher prereplicative BER model, where NEIL1, as
part of the replication complex, provides lesion surveillance to

Regulation Prereplicative Repair by NEIL1

prevent mutagenic replication (5, 34). Such dynamic complexes
have also been shown to exist in other cellular processes,
including transcription (42– 44). Constitutive association of
WT NEIL1 with chromatin, which is abrogated by deleting its
CTD, further raised the possibility that the preformed multiprotein complex, which is stabilized by binary interactions
involving this disordered CTD, is essential for the stable association of NEIL1 with chromatin. Our recent unpublished
observations6 suggest that chromatin association of BER complexes, including that of NEIL1, may also involve their interaction with key chromatin factors, including histones, histone
chaperones, etc., which is regulated via post-translational
modifications.
How such multiprotein complexes overcome structural or
steric constraints remains unexplored because of the lack of
appropriate experimental tools for in cellulo analysis. It is likely
that the intrinsic disorder in the interaction peptide provides
the flexible surface needed for allosteric changes to modulate
interactions among the components within the complex. Furthermore, pairwise binding among the partner proteins would
exponentially increase the stability of large functional complexes in cells. As a proof of concept, using recombinant NEIL1,
XRCC1, and Pol␤, which were previously shown to interact in a
pairwise fashion (30), we showed by size fractionation of the
mixture of these proteins that although the binary complexes
6

S. Sengupta, C. Yang, M. L. Hegde, and S. Mitra, unpublished observations.
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are not highly stable, the presence of all three proteins facilitates a significant amount of a stable ternary complex (⬎50% of
total protein; Fig. 10).
To investigate the biological importance of multiprotein BER
complexes containing NEIL1, we compared the repair efficiency of NEIL1(WT) versus NEIL1(N311), which lacks the
common interface for interaction with other repair proteins
and thus does not allow active complex formation. Although
the base excision/strand incision activities of NEIL1(WT) and
NEIL1(N311) are comparable (the CTD is dispensable for
NEIL1 DNA glycosylase activity), complete BER was significantly lower with the N311 mutant relative to the WT protein.
Together, these results suggest that repair by multiprotein complexes is much more efficient than that by non-complexed proteins. This could be particularly relevant in higher eukaryotes with
chromatinized DNA, where the impact of chromatin dynamics on
BER is still largely unknown. Although the basic chemistry of BER
is conserved from E. coli to mammals, its regulation is unique to
higher eukaryotes, including the mammals.
Finally, the in vivo relevance of the BERosome was confirmed
by the novel observation of BER inhibition by the NEIL1 CTD.
Our finding that this common interaction peptide functions as
a dominant negative inhibitor of BER both in vitro and in cellulo, by disrupting BERosome formation, could have significant
implications in cancer therapy. Similar interaction-inhibiting
peptides have been extensively used to modulate cellular outcomes with clinical relevance. Examples include a peptide
VOLUME 290 • NUMBER 34 • AUGUST 21, 2015
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FIGURE 8. Isolated CTD peptide of NEIL1 dominant negatively inhibits BER in vitro. A, 5-OHU-containing duplex oligonucleotide, end-biotinylated,
used in the LP-BER assay. B, dose-dependent inhibition of LP-BER activity by CTD (aa 312–389; lanes 1–5). The non-interacting CTD (aa 350 –389) peptide
does not affect BER (lanes 6 – 8). LP-BER activity of FLAG-NEIL1 IP was inhibited by recombinant CTD peptide (lanes 9 and 10). AU, arbitrary units. Error
bars, S.E.
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FIGURE 9. Ectopic introduction of CTD peptide sensitizes cells to oxidative stress by inhibiting BERosome formation. A, flow diagram depicting the
protocol to measure genome damage/repair after transduction of TAT/GFP-fused CTD peptides or transfection of FLAG-CTD plasmid, which was
confirmed by immunofluorescence or FITC-conjugated anti-FLAG antibody (B). C, estimation of oxidized base lesions by long amplicon PCR. Glucose
oxidase (GO)-induced DNA damage (measured at 0.5 and 5 h after glucose oxidase treatment) in HEK293 cells was measured by long amplicon PCR of
Fpg/EndoVIII-treated genomic DNA. Persistent damage was identified at 5 h in CTD fragment 289 –389-expressing cells but not in 350 –389-expressing
cells. D, TAT-CTD peptide transduction reduced RFC association with PCNA, Pol␦, or LigI as analyzed by PLA. Quantitation is shown as a histogram. E, a
clonogenic cell survival assay shows reduced survival of glucose oxidase-treated HEK293 cells expressing FLAG-NEIL1(289 –389) as compared with
vector control or non-interacting peptide (aa 350 –389). Error bars, S.E.

corresponding to the interaction domain of NFRF (NF-␤repressing factor) that inhibits NFRF-NF-␤ p65 interaction
and consequent IL-8 gene activation (45), and a STAT3derived phosphopeptide that inhibits its dimerization and
AUGUST 21, 2015 • VOLUME 290 • NUMBER 34

transcriptional activities (46, 47). Our study providing the
proof of concept of inhibiting in vivo BER by disrupting complex formation could be exploited to enhance tumor cell
susceptibility to drugs.
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FIGURE 10. Pairwise interaction between NEIL1, XRCC1, and Pol␤ stabilizes the ternary complex. A, analytical gel filtration chromatography profile
of NEIL1 ⫹ XRCC1, Pol␤ ⫹ XRCC1, or NEIL1 ⫹ XRCC1 ⫹ Pol␤. Whereas the
two-protein mixtures formed only a negligible fraction of stable complex
(peak 2), a significant portion of the mixture of three proteins exists in ternary
complex (peak 1). B, Coomassie staining of the peak fractions confirms the
ternary complex formation. Peaks 3, 4, and 5 represent monomeric XRCC1,
NEIL1, and Polb, respectively.
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